As of June 03, 2025, Editas Medicine (EDIT) has a market cap of $0.15 billion USD. According to our data, Editas Medicine is ranked No.7329 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jun 03, 2025 | $0.15 B |
43.31%
|
Dec 31, 2024 | $0.11 B |
-87.46%
|
Dec 29, 2023 | $0.85 B |
14.21%
|
Dec 30, 2022 | $0.74 B |
-66.59%
|
Dec 31, 2021 | $2.22 B |
-62.13%
|
Dec 31, 2020 | $5.87 B |
136.78%
|
Dec 31, 2019 | $2.48 B |
30.15%
|
Dec 31, 2018 | $1.90 B |
-25.97%
|
Dec 29, 2017 | $2.57 B |
89.34%
|
Dec 30, 2016 | $1.36 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Intellia Therapeutics
NTLA
|
$0.79 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.15 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.69 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$48.67 M |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.51 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.10 M |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.15 B |
43.672 M
|
![]() France
|
![]() Allogene Therapeutics
ALLO
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Sana Biotechnology
SANA
|
$0.53 B |
-0.000 M
|
![]() USA
|
![]() Verve Therapeutics
VERV
|
$0.43 B |
-0.000 M
|
![]() USA
|
Market Cap | = | EDIT Stock Price | * | EDIT Shares Outstanding |
= | $1.82 | * | 83.71 M | |
= | $0.15 B |